Felycin-CA1

(sirolimus delayed-release tablets)

Indicated for the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM). Conditionally approved by FDA pending a full demonstration of effectiveness under application 141-604.

FE0710 - Felycin-CA1 tablets 0.4mg, 12 tablets/ box

FE0711 - Felycin-CA1 tablets 1.2mg, 12 tablets/ box

FE0712 - Felycin-CA1 tablets 2.4mg, 12 tablets/ box

This is a prescription only medication, please use according to your veterinarian's instruction. If you have any concerns about your pet’s health or any treatment, please do not hesitate to consult your veterinarian, who can provide personalized care and recommendations.

If you have any concerns about your pet’s health, please do not hesitate to consult your veterinarian, who can provide personalized care and recommendations.

Veterinary clinics interested in this product are invited to contact our team via this link for pricing details and further information.

Thank you.